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Abstract
Background: The atrial natriuretic peptide (ANP) family is a complex system consisting of at least three polypeptides and at least three
types of receptor. Each peptide interacts with different types of receptor at varying degrees of afﬁnity. To determine if natriuretic peptide
levels inﬂuence natriuretic peptide receptor expression and regulation, we examined the expression of guanylyl cyclase linked GC-A,
GC-B and C-receptor in the lungs of mice with a mutation that inactivates the ANP gene (Nppa). Methods: The mRNA level of GC-A,
GC-B and C-receptor in the lung were studied by ribonuclease protection assays (RPA). Results: Results of RPA showed that although the
mRNA level of GC-A and GC-B of heterozygous ANP1/2 was not different from wild type ANP1/1 mice, they were signiﬁcantly
higher in the homozygous mutant ANP2/2 mice. In addition, C-receptor mRNA level in ANP1/2 and ANP2/2 was signiﬁcantly
lower than ANP1/1 mice. The C-receptor results were conﬁrmed by receptor binding assays and afﬁnity cross-linking studies.
Conclusions: Taken together these data suggest that permanent removal of ANP from the natriuretic peptide system results in an
up-regulation of GC-A and GC-B, and a corresponding down-regulation of C-receptor in the lung of proANP gene disrupted mice. We
postulated that changes in the natriuretic peptide receptor population may result in chronic hypertension and cardiac hypertrophy in the
ANP2/2 mice. Ó 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction whereas CNP is mainly found in the central nervous
system [3]. Recent studies indicate CNP may function
Natriuretic peptides (NPs) are a family of three closely outside the central nervous system. CNP has been impli-
related polypeptides: atrial natriuretic peptide (ANP or cated as an endothelial factor that may be involved in the
A-type), brain natriuretic peptide (BNP or B-type), and regulation of vascular smooth muscle cell proliferation
C-type natriuretic peptide (CNP). ANP and BNP are [4,5]. CNP mRNA has also been localized in the reproduc-
cardiac hormones with potent diuretic, natriuretic and tive system of the mouse [6].
vasorelaxant properties that are known to regulate body The actions of natriuretic peptides are mediated by a
ﬂuid homeostasis and blood pressure [1] by interacting family of three receptor types. Two of these receptors
with at least three distinct natriuretic peptide receptors [2]; (GC-A and GC-B) are guanylyl cyclase-linked and thought
to mediate the biological actions of ANP via modulation of
cyclic GMP concentrations [7,8]. The GC-A receptor
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lower afﬁnity for CNP. The GC-B receptor exhibits high (1/2) produced F2 offspring of all three genotypes (1/1
afﬁnity for CNP and lower afﬁnity for ANP and BNP. The , 1/2, 2/2) in Mendelian proportions.
third receptor, C-receptor, which is not linked to guanylyl The mice used in this study were obtained from an
cyclase, is thought to function as clearance receptor that established colony at Queen’s University by crossbreeding
serves to remove excess natriuretic peptides from the of 1/2 mice and the genotype of offspring (i.e. 1/1,
circulation [9]. The C-receptor has similar afﬁnities to all 1/2 and 2/2) was determined by Southern blot analysis.
three natriuretic peptides [10]. F6 to F8 generations of mice of both sexes from 20 to 24
To help deﬁne the exact physiological role of ANP and weeks old and weighing 25–35 g were used in this study.
to understand how natriuretic peptides and their receptors The animals were housed according to sex in groups of
are regulated, a mouse model of ANP gene disruption was two to six per cage and kept at an ambient temperature of
established [11]. In the present investigation, we examine 228C and 40% humidity in a room with a 12-h light/dark
the expression of GC-A, GC-B and C-receptor in mice that cycle.
produce normal level (ANP1/1), half normal level The physical characteristics of the mice at F6 to F8
(ANP1/2) or no ANP (ANP2/2) using ribonuclease generations have been published elsewhere [12,13]. Brieﬂ-
protection assay (RPA), receptor binding assay, afﬁnity y, the arterial blood pressures (in mmHg) obtained from a
cross-linking study and autoradiography. direct carotid arterial cannula in inactin-anesthetized ani-
mals were 9566 for ANP1/1 and 11662 for ANP2/2
mice (P#0.0001) and the corresponding heart rate (in
beats/min) was 460630 and 470620 (P.0.05), respec-
2. Methods tively.When mice were treated with 8% salt in the diet for
at least 2 weeks, the arterial blood pressure (in mmHg)
Experimental protocols included in this manuscript have was 11369 for ANP1/1 and 13563 for ANP2/2 mice.
been approved by the Animal Care Committee of Queen’s For genotyping, genomic DNA was isolated from mouse
University in accordance with the guidelines of the Cana- tail by proteinase K digestion followed by a phenol–
dian Council on Animal Care. chloroform extraction. The genomic DNA was digested
with EcoRI and electrophoresed on a 0.6% agarose/TBE
gel and transferred to a nylon membrane. The membrane
2.1. Peptides and chemicals was probed with a random-primed, digoxigenin-labeled
DNA probe targeted to an 850 bp portion of the ANP gene
18 Synthetic rANP and C-ANP (des[Gln – which extends from exon 1 to exon 3. Speciﬁcally-labeled (99–126) (4–23)
19 20 21 22 bands were detected by an anti-DIG-AP antibody using Ser –Gly –Leu –Gly ]-ANP ) were synthesized (4–23)
enhanced chemiluminescent detection (Boehringer Mann- by the Core Facility for Protein/DNA Chemistry, Queen’s
heim, Canada). University. Chloramine T, phenylmethylsulfonyl ﬂuoride
Thirty mice were used in this study. Fifteen mice (ﬁve (PMSF), leupeptin, bacitracin, bovine serum albumin
from each genotype) were used to determined receptor (BSA), and sodium lauryl sarcosine were purchased from
mRNA levels by RPA, and a similar set of 15 mice were Sigma Chemicals (St. Louis, MO, USA), disuccinimidyl
used for in vitro binding and afﬁnity cross-linking assays. suberate (DSS) from Pierce Biochemicals (Rockford, IL,
125 USA) and guanidinium thiocyanate, and Na I from ICN
2.3. Studies with ribonuclease protection assay (RPA) (Costa Mesa, CA, USA). RNase T and RNase A were 1
obtained from Amersham (Oakville, ON, Canada) and
2.3.1. Isolation of cDNA probes for mouse A-, B- and Proteinase K was purchased from Gibco BRL (Burlington,
32 C-type receptor by PCR Canada). [a- P]CTP was purchased from NEN (Guelph,
The complementary DNA (cDNA) fragments corre- ON, Canada). All other reagents used in this study were
sponding to the extracellular domain of mouse GC-A, reagent grades and purchased from BDH (Mississauga,
GC-B and C-receptor were obtained from mouse kidney ON, Canada).
(for GC-B and C-receptor) and atrium (for GC-A) by
reverse transcriptase linked polymerase chain reaction
2.2. ProANP gene disrupted mice (RT-PCR). PCR was carried out using the following
synthetic oligonucleotides as primers:
The production of the ANP gene disrupted mice has
been described previously [11]. In brief, 11 nucleotides of GC-A receptor: Antisense primer 59-CCTCCAGTGTGGAAAAGTG-39
exon 2 of the proANP gene (Nppa) were replaced with the Sense primer 59-GAGCGACCTGACCGTGGCT-39
neomycin resistance gene in embryonic stem cells of GC-B receptor: Antisense primer 59-TTGCCAGAGTGGAAAGTGG-39
mouse strain 129. Chimeras harboring the mutation were Sense primer 59-ACGGAACCTGACGCTGGCG-39
then mated to mice strain C57BL/6J (B6). Matings C-receptor: Antisense primer 59-CTTCTAGGCCACATGATTT-3
between the resulting 129 and C57BL/6J heterozygotes Sense primer 59-AGAGGCGCTGGCGGCTCAA-39
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Fragments of PCR product were then subcloned in pCRII Rafael, CA, USA). The reading of each sample was
vector (Invitrogen). normalized with that of the corresponding GAPDH band.
2.3.2. DNA sequencing 2.4. Receptor binding studies
The identity of the ampliﬁed fragments was conﬁrmed
by sequencing using M13 forward and M13 reverse 2.4.1. Iodination
primers. DNA sequencing was conducted by the Core Iodination of synthetic rANP was performed by (99–126)
Facility for Protein/DNA Chemistry, Queen’s University, the chloramine T method as previously described by Sarda
Kingston, Ontario, Canada by means of an Applied et al. [15]. Radiolabeled peptides were puriﬁed on a Sep-
Biosystems 373A DNA Sequencer. Pak C resin cartridge (Waters Associates, Milford, MA, 18
USA), followed by HPLC on a reversed-phase Vydac C18
2.3.3. Tissue and RNA preparation column with a linear gradient elution using a solvent
Tissues were excised from sodium pentobarbital (45 system of water/acetonitrile/0.1% triﬂuoroacetic acid at a
mg/kg) anaesthetized mice, frozen immediately in liquid ﬂow-rate of 1 ml/min.
nitrogen and stored at 2808C until assay. Lungs from
individual mice were homogenized with a polytron and the 2.4.2. Preparation of mouse lung membranes
RNA was extracted by the acid guanidinium thiocyanate–
Frozen mouse lungs were thawed and rinsed in 0.9%
phenol–chloroform method [14] and quantiﬁed by spectro-
saline. The tissue was then minced and homogenized in a
photometry (Hewlett-Packard 8452A).
Teﬂon/glass homogenizer with ten volumes of cold 10
mM MgCl , 10 mM Hepes pH 7.5, 10 mM NaCl, 5 mM 2 2.3.4. Ribonuclease protection assay (RPA)
PMSF, 5 mg/ml leupeptin and 5 mg/ml pepstatin. The
Template cDNA for cRNA synthesis were prepared as
homogenate was centrifuged at 20003g for 10 min at 48C
follows: (1) in the case of templates for GC-A and GC-B
and the pellet discarded. The membrane in the supernatant
receptor, EcoRI–PstI fragment of exon 1 of GC-A or
was then pelleted by centrifugation at 16 0003g for 15
GC-B were subcloned into plasmid pGEM-3Z (Promega).
min at 48C. The membrane pellet was collected and then
An AvaI–AvaI fragment of the C-receptor was subcloned
resuspended in 10 mM NaHCO at pH 8 containing 5 mM 3 into pGEM-3Z. The GC-A and GC-B plasmids were
PMSF, 5 mg/ml leupeptin and 0.1% bacitracin and stored
linearized with RsaI and the C-receptor plasmid was
at 2708C. Protein concentration was determined by a
linearized with SacI. Respective antisense cRNA probes
modiﬁed method of Lowry et al. [16] using BSA as a 32 were synthesized using [a- P]CTP as tracer in the pres-
standard.
ence of T7 RNA polymerase for C-receptor or SP6 RNA
polymerase for GC-B and GC-A receptors, and GAPDH
2.4.3. Receptor binding assays (Ambion, Austin, TX, USA). The polyacrylamide gel-
6 The method of Weir et al. [10] was used to study puriﬁed riboprobes (2.5–5310 cpm) and total RNA (20
receptor binding of ANP in vitro. Brieﬂy, binding assays mg) were denatured at 858C for 10 min and annealed
were performed on ice in a buffer containing 50 mM overnight at 558C in 80% formamide, 40 mM PIPES pH
Hepes pH 7.5, 5 mM MgCl , 10 mM NaCl, 1 mM PMSF, 2 6.5, 0.4 M NaCl, and 1 mM EDTA. Ribonuclease diges-
2 mg/ml leupeptin, 0.1% BSA and 0.1% bacitracin. The tion buffer (200 ml; 10 mM Tris pH 7.5, 5 mM EDTA, and
125 binding reaction was initiated when [ I]rANP(99–126) 300 mM NaCl) containing 2 mg/ml RNase T and 40–50 1
(60 000–80 000 cpm) and varying amounts of competing, mg/ml RNase A was then added and incubation continued
unlabeled ligand were added to 30 mg of lung membranes. for 30 min at 308C. Proteinase K and SDS were added to a
Triplicate samples were incubated on ice for 60 min and ﬁnal concentration of 0.2 mg/ml and 0.7%, respectively.
then centrifuged at 16 0003g for 10 min at 48C to separate The mixture was gently mixed and incubated for 30 min at
the free from bound peptide. Membrane pellets were 378C. After phenol–chloroform extraction, 20 mg tRNA
washed with 10 mM Hepes containing 10% sucrose at pH was added and the RNA was precipitated with two
7.5. The resultant membrane pellet with bound, labeled volumes of 100% ethanol. The precipitate was washed
ANP was quantiﬁed with a LKB Wallac gamma counter with 100% ethanol, dried, and resuspended in buffered
(Model [1275 Minigamma). formamide. Samples were denatured (958C for 5 min) and
electrophoresed on an 8% polyacrylamide sequencing gel.
2.4.4. Afﬁnity cross-linking studies The gels were dried and exposed to Dupont Reﬂection
Afﬁnity cross-linking studies were performed according NEF-469 ﬁlms with intensifying screen at 2708C.
to the method of Weir et al. [10]. Brieﬂy, lung membranes
pooled from three mice of each genotype (100 mg) were 2.3.5. Analysis of gels
incubated for 1 h on ice in 250 ml of binding buffer (50 The integrated optical density of the radioactive bands
mM Hepes pH 7.5, 5 mM MgCl , 10 mM NaCl, 1 mM was scanned by a Hewlett-Packard Scanjet IIcx/T and 2
6 125 analyzed by SigmaGel (Jandel Scientiﬁc Software, San PMSF and 0.1% BSA) with 1310 cpm [ I]rANP(99–126)
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in the absence or presence of either 1 mM unlabeled ANP After 4 weeks of exposure at 48C, the slides were
or 0.1 mM C-ANP. Samples were centrifuged at 16 0003g developed in Kodak D-19 developer, ﬁxed in sodium
for 10 min at 48C to separate the free from bound peptide. thiosulphate and rinsed in distilled water. The slides were
The membrane pellets were washed and resuspended in 50 then counter-stained with haematoxylin and eosin.
mM sodium phosphate (pH 7.5). DSS dissolved in DMSO
was added at a ﬁnal concentration of 0.5 mM and samples
were incubated at 48C for 15 min. The reaction was 2.6. Statistics
quenched by addition of 1 M Tris (pH 7.0) for 15 min at
48C and membranes were collected by centrifugation at All values were expressed as mean and standard error.
16 0003g for 10 min. The membrane pellets were re- Data were analysed by a one-way ANOVA followed by
suspended in SDS gel sample buffer containing 5% (v/v) Tukey’s test and a P#0.05 was considered to be statistical-
b-mercaptoethanol and boiled for 5 min. Samples were ly signiﬁcant.
analyzed by SDS polyacrylamide gel electrophoresis using
a 3.5% stack gel and a 7.5% separating gel. Dried gels
were exposed to DuPont Reﬂection NEF-496 ﬁlm with
intensifying screen at 2708C. 3. Results
2.5. Autoradiographic studies 3.1. RPA studies
For autoradiographic studies, mice were prepared ac- A comparison of the mRNA levels of the three NP
cording to the method of Pang et al. [17]. Brieﬂy, mice receptors was performed to evaluate the inﬂuence of ANP
were anaesthetized with sodium pentobarbital (45–50 mg/ on NP receptor expression. Fig. 1 shows the results of
kg) and the left jugular vein was cannulated for bolus RNase protection assay (RPA) for the mRNA levels of the
6 infusion of ANP. Then, 10310 cpm of three NP receptors in the lung for each genotype. The
125 [ I]rANP were intravenously injected either alone densitometric determination of the relative abundance of (99–126)
or with corresponding unlabeled ANP (10 mg) into each GC-A, GC-B and C-receptor mRNA from the RPA experi-
mouse. Two min after injection, mice were perfused ments are presented in Fig. 2. The results shown in Fig. 2
through the heart ﬁrst with normal saline and then with 4% are normalized for the differences in loading by determin-
peraformaldehyde in 0.1 M phosphate buffer (pH 7.4). ing the amount of GAPDH mRNA as an internal control.
Lungs were excised and processed for embedding in In homozygous mutant (2/2) mice, expression of the lung
parafﬁn wax. Finally, 4–5-mm sections were cut and C-receptor mRNA was signiﬁcantly decreased when com-
mounted onto glass slides, dried, dewaxed, rehydrated in a pared with that of the wild type mice. In the 2/2 mice,
series of graded ethanol, rinsed in doubled distilled water the expression of mRNA for GC-A and GC-B receptors
and air dried. In the dark, the sections were dipped in were signiﬁcantly increased when compared with that in
Amersham LM-1 emulsion and air dried. the 1/1 mice.
Fig. 1. The mRNA expression of ANP receptors in the mouse lung was examined by ribonuclease protection analysis of total RNA (20 mg) isolated from
mouse tissues using a riboprobe speciﬁc for the mouse GC-A receptor exon 1 (panel A), GC-B receptor exon 1 (panel B), C-receptor exon 1 (panel C) and
GAPDH (panel D). The following lung samples were assayed: ﬁve mice from each of 1/1, 1/2, 2/2.
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Fig. 3. The equilibrium binding curve for the NP receptors in the lung of
the ANP gene disrupted mice. The values obtained were from in vitro
binding studies of isolated lung membranes. The binding characteristics
of the NP receptors did not differ signiﬁcantly between genotypes.
similar, indicating that the natriuretic peptide receptor
system remains intact for the ANP gene disrupted mice.
IC values of 0.32, 0.35 and 0.35 nM were determined for 50
the wild type (1/1), heterozygous (1/2) and homo-
zygous mutant (2/2) mice, respectively.
The total and C-receptor population are shown in Fig. 4.
The population of the C-receptor in lung membrane was
determined by using C-ANP (a speciﬁc ligand for the
C-receptor) [9] as the unlabeled competing peptide in the
binding study. The total binding sites for the three geno-
types of mice were similar. However, a signiﬁcantly lower
binding to the C-receptor was noted in the ANP2/2 as
compared with the 1/1 and 1/2 mice. It is noteworthy
that the 1/2 mice demonstrated a highest degree of
variability for the C-receptor population.
Fig. 2. Natriuretic peptide receptor mRNA levels as determined by RPA
and quantiﬁed by SigmaGel software (see Methods section for detail). All 3.2.2. Afﬁnity cross-linking study
125 values were normalized relative to GAPDH mRNA levels. * Represents Afﬁnity cross-linking of [ I]rANP to the lung (99–126) data which were statistically signiﬁcant as determined by ANOVA membrane indicates the presence of two protein species
followed by a post-hoc Tukey’s test. A value of P#0.05 was considered
which bind ANP speciﬁcally (Fig. 5, lane 1). The lower statistically signiﬁcant. As evident in this ﬁgure, there was a higher
(65 kDa) C-receptor band was speciﬁcally competed off mRNA level of GC-A and GC-B and a lower mRNA of C-receptor in the
ANP2/2 mice. when C-ANP was used as the unlabeled peptide (Fig. 5,
lane 2). Competition of both receptors occurred when
rANP was used as the competing ligand (Fig. 5, (99–126) 3.2. Binding studies
lane 3). The ratio between GC-A1GC-B and C-receptor of
1/1, 1/2, and 2/2 was 1.1, 2.3 and 3.4, respectively. 3.2.1. Competitive binding of ANP to mouse lung mem-
brane
The total binding curves obtained from the equilibrium 3.2.3. Autoradiographic studies
binding study using rANP as the unlabeled compet- Autoradiographic studies showed that with labeled ANP (99–126)
ing ligand are shown in Fig. 3. The binding afﬁnities for alone, most of the silver grains were located on the lung
rANP of each of the three genotypes were very parenchyma, intrapulmonary vasculature and very few (99–126)
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velopment of salt-sensitive hypertension in ANP2/2 mice
is time dependent with a latency of at least 1 week and
may be related to their inability to reduce plasma renin
activity following high salt treatment.
The present study was designed to determine the expres-
sion of natriuretic peptide receptors in the lung of ANP
gene disrupted mice. Our hypothesis is that ANP is
involved in the regulation of receptor expression under
chronic situations. The study by Liu and Yoshimi [19] on
DOCA-salt hypertensive rats has shown that the effect of
down regulation of the C-receptor in the lung was larger
than that in the kidney, suggesting that the lung may play a
dominant role in the regulation of the clearance of ANP
through C-receptors in vivo. Accordingly, removal of ANP
will result in changes in natriuretic peptide receptor
expression leading to an altered state of natriuretic peptide
function and hypertension. We have chosen the lung as a
model system for this study because previous studies have
125 shown a high level of binding of I-labeled ANP to this
organ and also the lung has been implicated to play a vital
role in the clearance of ANP, suggesting that this organ
may be important in the overall function of the natriuretic
peptide system [17–20].
We have developed a highly sensitive RPA for each of
the three natriuretic peptide receptors. Our data demon-
strated that the overall animal to animal variability appears
to be quite high. The high degree of variability could
perhaps be attributed to the differences in the genetic
Fig. 4. The natriuretic peptide receptor population in the lung of the ANP background in the F6 to F8 generation mice used in this gene disrupted mice. The values shown were obtained from in vitro
study. In spite of the variation in the levels of mRNA binding studies with 30 mg of protein from isolated lung membranes.
within each group, a statistical difference in the levels of * Represents data which were statistically signiﬁcant as determined by
ANOVA followed by a post-hoc Tukey’s test. A value of P#0.05 was mRNA in each genotype does occur. Results show that
considered statistically signiﬁcant. This ﬁgure shows that the amount of there is an overall up-regulation of GC-A and GC-B and
C-receptor binding to isolated lung membrane from ANP2/2 was down-regulation of C-receptor in the ANP2/2 mice. signiﬁcantly lower than that from ANP1/1 or ANP1/2 mice.
Interestingly, GC-A and GC-B levels in ANP1/2 were
not different from the 1/1 mice. On the other hand, the
were over the bronchial tree (Fig. 6). Virtually no silver level of C-receptor in the 1/2 was similar to the 2/2
grain was detected over the section when both ‘hot’ and mice. It is possible that the reduced C-receptor in the lung
‘cold’ ANP were infused at the same time. There was no of ANP1/2 mice is a reﬂection of the reduced circulating
detectable difference between the ANP1/1 and ANP2/ ANP level [11] or modiﬁcation of expression of BNP and
2 mice. CNP in these animals.
To investigate whether or not down-regulation of C-
receptor mRNA is reﬂected in the overall binding of ANP
4. Discussion to its receptors, we studied the binding of labeled ANP
with lung plasma membrane preparation using a receptor
In order to understand the physiological role of ANP, a binding assay. The binding of ANP to C-receptors was
mouse model with disruption of the proANP gene has been determined using C-ANP (a speciﬁc ligand for C-receptor)
developed [11]. It has been shown that the homozygous as the unlabeled competing peptide in the assay. Our
mutant (ANP2/2) mice exhibit elevated arterial blood results show that although the total binding sites for the
pressure (compare to the wild type ANP1/1 or hetero- three genotypes of mice were similar, there was a sig-
zygous ANP1/2) and have no circulating or atrial ANP. niﬁcantly lower binding of ANP to the C-receptor in the
Furthermore, results from the initial characterization sug- ANP2/2 as compared with the 1/1 and 1/2 mice. It
gest that genetically-reduced production of ANP, as in therefore follows that there is a corresponding increase in
ANP1/2 mice, can lead to salt-sensitive hypertension. A binding of ANP to GC-A and GC-B receptors in the
recent report from Melo et al. [12] have conﬁrmed this ANP2/2, supporting the ﬁndings of the RPA study in the
observation. In addition, they demonstrated that the de- present investigation.
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125 Fig. 5. Afﬁnity cross-linking of labeled ANP to isolated lung membranes. Lane 1 represents the in vitro binding of [ I]rANP in the absence of (99–126)
125 unlabeled ANP. Lane 2 represents competitive binding of [ I]rANP in the presence of C-ANP (a ligand which speciﬁcally binds only to the (99–126)
125 C-receptor). Lane 3 represents the nonspeciﬁc binding of [ I]rANP to lung membranes. In this case, 1 mM unlabeled ANP was used to (99–126) (99–126)
speciﬁcally saturate the NP receptors. This ﬁgure shows that the ratio between GC-A/GC-B and C-receptor was increased in the 1/2 and 2/2 mice,
suggesting that the level of C-receptor was reduced in these animals as compared with the 1/1 mice.
Results from the afﬁnity cross-linking study further Although the relation between the expression of nat-
substantiate the ﬁnding that there is an overall down riuretic peptides and their receptors is not fully understood,
regulation of C-receptor. When there was no competitor in studies have suggested that under certain pathological
the assay, the ratio between C-receptor and the GC-cou- conditions such as hypertension, the elevated level of
pled receptors in 1/1 mice is about 1:1. However, the natriuretic peptides is correlated with a down-regulation of
ratio was much higher (1:3.4) in the 2/2 mice, sug- their receptors [21]. Using the ANP gene disruption mice
gesting that the population of the GC-coupled receptors is as a model, our data have provided direct evidence that
much higher than that of the C-receptors. In each geno- removal of ANP resulted in a down-regulation of C-
type, ANP binding to the C-receptor was speciﬁcally receptor and a corresponding up-regulation of GC-A and
competed off with C-ANP. Interestingly, a faint residual GC-B receptors in ANP (2/2) mice under chronic
C-receptor band remains in the 1/1 mice even after the situations. A down-regulation of the C-receptor would
addition of C-ANP. Subsequent cross-linking studies, result in a reduced rate of clearance of the remaining
where the C-ANP concentration has been increased three- natriuretic peptides (BNP or CNP) resulting in an overall
125 fold, has shown a complete competition of the I- ampliﬁcation of the effect of BNP or CNP.
ANP binding. Since ANP binds to all NP receptors, In summary, we have demonstrated that disruption of 99–126
all bands disappeared when ANP was used as the compet- the ANP gene results in a redistribution of the three
ing ligand. natriuretic peptide receptors in the lung in the absence of
Autoradiographic studies showed that the binding of ANP. Despite a down-regulation of the C-receptor and a
labeled ANP is mainly in lung parenchyma and intra- corresponding up-regulation of the GC-coupled receptors,
pulmonary vasculature, but not in the bronchial tree. There the 2/2 mice are still chronically hypertensive. The
were very few silver grains (i.e. binding) present over notion whether altered expression of these receptors can
either the intra-pulmonary bronchi, bronchioles or terminal lead to chronic hypertension and cardiac hypertrophy in
bronchioles. These data suggest that ANP receptors are the ANP2/2 remains to be determined. Clearly the next
mainly located in the pulmonary vasculature and not the logical step is to examine the expression of BNP and CNP
conducting portion of the respiratory system in the mouse. in the ANP gene disrupted mouse model to see whether
Infusion of labeled ANP with excess of unlabeled ANP they have been modiﬁed in response to the lack of ANP.
completely eliminated the binding of ANP in the lung. Overall, the in vivo redistribution of NP receptors in
There is no detectable differences between the binding of response to the lack of ANP, perhaps, prevents the
ANP in the ANP1/1 and the ANP2/2 mice. disruption of the ANP gene from being lethal. Alter-
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Fig. 6. Autoradiographic studies of in vivo tissue binding of labeled ANP alone (a, c) and labeled plus unlabeled ANP (b, d) in lung tissues of ANP1/1
and ANP2/2 mice, respectively. Labeled ANP bound mainly to the lung parenchyma and many of the intrapulmonary vasculature (BV), but not to the
bronchial tree (B). Speciﬁc binding of labeled ANP was veriﬁed by infusing labeled ANP with excess of unlabeled ANP (b, d) where all the binding was
competed off. Calibration bar530 mm.
natively, it is also possible that other endocrine systems Wills High School Summer Studentship provided by the
such as the renin–angiotensin–aldosterone system may be Heart and Stroke Foundation of Canada.
modiﬁed in response to the lack of ANP. Further in-
vestigation is required in order to deﬁne the relative role of
these two systems in blood pressure control and body ﬂuid References
homeostasis.
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